NALP14, also known as NLRP14, is a member of the NOD-like receptor (NLR) family, which plays a significant role in the immune system, particularly in the regulation of inflammatory and apoptosis processes through the assembly of inflammasome complexes. NALP14 is particularly interesting due to its expression largely being restricted to the testis, suggesting a specialized role in spermatogenesis or fertility. It is hypothesized that NALP14 may participate in controlling immune responses within the testis, potentially influencing the maturation and survival of sperm cells. The exact mechanisms through which NALP14 functions are not fully understood, but it is likely involved in the detection and response to cellular stress or pathogenic components, thereby contributing to the maintenance of cellular integrity in reproductive tissues.
The inhibition of NALP14 could potentially affect fertility and immune regulation within the testis. Such inhibition might be achieved through several biochemical pathways or intervention strategies. One common approach could involve the use of RNA interference, such as siRNA, specifically designed to target and reduce the expression of NALP14 mRNA, effectively decreasing its protein levels within the cells. This reduction could help to elucidate the protein's function in testis physiology and inflammation-related processes. Another method of inhibition could be the development of small molecule inhibitors that directly interfere with the protein's ability to interact with other inflammasome components or substrates, thereby inhibiting its function. Additionally, blocking the signaling pathways downstream of NALP14 activation, potentially through the use of specific kinase inhibitors that prevent the phosphorylation steps necessary for inflammasome assembly, could also serve as a means to inhibit its activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Parthenolide | 20554-84-1 | sc-3523 sc-3523A | 50 mg 250 mg | $81.00 $306.00 | 32 | |
Inhibits NF-κB activation, affecting pathways in which NALP14 could be involved. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
Irreversibly inhibits IκBα phosphorylation affecting NF-κB pathways related to NALP14. | ||||||
VX-765 | 273404-37-8 | sc-475845 sc-475845A sc-475845B | 5 mg 10 mg 50 mg | $228.00 $302.00 $968.00 | 1 | |
Inhibits caspase-1, affecting inflammasome activities that may involve NALP14. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Disrupts actin polymerization, affecting cellular structures and pathways associated with NALP14. | ||||||
Glyburide (Glibenclamide) | 10238-21-8 | sc-200982 sc-200982A sc-200982D sc-200982B sc-200982C | 1 g 5 g 25 g 100 g 500 g | $46.00 $61.00 $117.00 $173.00 $530.00 | 36 | |
Inhibits NLRP3 inflammasome, which may indirectly modulate NALP14. | ||||||
Niflumic acid | 4394-00-7 | sc-204820 | 5 g | $32.00 | 3 | |
Anion channel inhibitor that can affect ion flux, influencing NALP14's involvement in inflammasome. | ||||||
CA-074 | 134448-10-5 | sc-202513 | 1 mg | $321.00 | ||
Inhibits Cathepsin B, affecting lysosome integrity and subsequent inflammasome assembly including NALP14. | ||||||
Andrographolide | 5508-58-7 | sc-205594 sc-205594A | 50 mg 100 mg | $15.00 $40.00 | 7 | |
Inhibits NF-κB activation, thereby modulating pathways involving NALP14. | ||||||
QNZ | 545380-34-5 | sc-200675 | 1 mg | $117.00 | 12 | |
Inhibits NF-κB activation, affecting the expression of genes that may involve NALP14. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Modulates multiple signaling pathways, including those involving NF-κB, which can affect NALP14. | ||||||